Promising Potential of Merus’s Petosemtamab in HNSCC: A Buy Recommendation
Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Merus (MRUS – Research Report) yesterday and set a price target of ...
Promising Clinical Trial Results Position Arvinas for Market Success
H.C. Wainwright analyst Andrew Fein maintained a Buy rating on Arvinas Holding Company (ARVN – Research Report) today and set a price target of ...